Report - FY2017 FINANCIAL RESULTS ENDED MARCH31, 2018...FY16 FY17 XTANDI/OAB products Dermatology business transfer * Fximpacts Long listed drug transfer** SALES ANALYSIS (YEAR ON YEAR) 8 (billion

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form